Stay updated with breaking news from Devika Syamnath. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(Reuters) - Keurig Dr Pepper missed market expectations for fourth-quarter sales on Thursday as higher product prices deterred demand for the beverage maker's sodas and tonic water. Beverage makers have been hiking prices in a bid to counter soarin...
The widespread use of powerful new weight-loss drugs in the United States could boost gross domestic product by 1% in the coming years as lower obesity-related complications are likely to boost...
U.S. federal government agencies including the FBI and the Department of Homeland Security are investigating whether the widespread AT&T outage on Thursday was the result of a cyber attack or a hack,...
Pause on export approval process will not slow expansion plans, CEO tells analysts. [Image credit: Cheniere Energy]
Some analysts have predicted the market for weight-loss drugs could reach $100 billion a year by the end of the decade, with Ozempic maker Novo Nordisk and Mounjaro producer Eli Lilly leading the race. The use of GLP-1s could increase by anywhere between 10 to 70 million consumers by 2028, Goldman Sachs said on Thursday. "If GLP-1 usage ultimately increases by this amount and results in lower obesity rates, we see scope for significant spillovers to the broader economy," Goldman economists said in a note.